Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Shared Care During Breast and Colorectal Cancer Treatment

Is It Associated With Patient-Reported Care Quality?

Doose, Michelle; McGee-Avila, Jennifer; Stroup, Antoinette M.; Ferrante, Jeanne; Xu, Baichen; Herman, Natalia L.; Demissie, Kitaw; Tsui, Jennifer

The Journal for Healthcare Quality (JHQ): February 27, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/JHQ.0000000000000192
Original Article: PDF Only
Buy
PAP

ABSTRACT There is growing evidence that shared care, where the oncologist, primary care physician, and/or other specialty physicians jointly participate in care, can improve the quality of patients' cancer care. This cross-sectional study of breast and colorectal cancer patients (N = 534) recruited from the New Jersey State Cancer Registry examined patient and health system factors associated with receipt of shared care during cancer treatment into the early survivorship phase. We also assessed whether shared care was associated with quality indicators of cancer care: receipt of comprehensive care, follow-up care instructions, and written treatment summaries. Less than two-thirds of participants reported shared care during their cancer treatment. The odds of reporting shared care were 2.5 (95% CI: 1.46–4.17) times higher for colorectal than breast cancer patients and 52% (95% CI: 0.24–0.95) lower for uninsured compared with privately insured, after adjusting for other sociodemographic, clinical/tumor, and health system factors. No significant relationships were observed between shared care and quality indicators of cancer care. Given a substantial proportion of patients did not receive shared care, there may be missed opportunities for integrating primary care and nononcology specialists in cancer care, who can play critical roles in care coordination and managing comorbidities during cancer treatment.

For more information on this article, contact Jennifer Tsui at jk1341@cinj.rutgers.edu.

The Improving Patient Access to Quality Cancer Treatment (IMPACT) Pilot Study was supported by the Rutgers Biomedical Health Sciences Team Science Initiative. The New Jersey State Cancer Registry is funded by National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program contract #HHSN261201300021I, the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) #5U58DP003931-02, the State of New Jersey, and the Rutgers Cancer Institute of New Jersey. M. Doose and J. McGee-Avila support for this project was provided by grants from the Robert Wood Johnson Foundation Health Policy Research Scholars program.

The authors declare no conflicts of interest.

© 2019 National Association for Healthcare Quality
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website